| Anthony Raymond Ignocheck, MD | |
|
1202 State St, Erie, PA 16501-1914 | |
| (814) 454-4530 | |
| (814) 456-2375 |
| Full Name | Anthony Raymond Ignocheck |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 1202 State St, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023017894 | NPI | - | NPPES |
| 00051110001 | Other | NY | UNIVERA |
| 183255 | Other | PA | BLUE SHIELD |
| 01982489 | Other | PA | NY MEDICAL ASSISTANCE |
| P000398 | Other | PA | GATEWAY |
| 66426 | Other | PA | UNISON |
| 080094059 | Other | PA | RR MEDICARE |
| 518504 | Other | PA | AETNA |
| 0011703370002 | Medicaid | PA | |
| 212566 | Other | PA | UPMC |
| 2472864 | Other | OH | OH MEDICAL ASSISTANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD036366E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurse Association Of Erie County | Erie, PA | Home health agency |
| Upmc Hamot Hospital | Erie, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Net | 1759290588 | 10 |
News Archive
Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France, the appearance of new CVBDs in Germany, the state of heartworm infection in Korea and the neurological impact on humans of long-term bartonella infection from the USA are among the papers now available for download from http://www.cvbd.org, as the proceedings of the 5th Annual Canine Vector Borne Disease (CVBD) World Forum are made available online today.
The Wistar Institute today obtained a U.S. patent for a novel synthetic vaccine technology with the potential for further development into a universal flu vaccine which could eliminate the need for annual flu shots and protect against future flu pandemics.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
› Verified 6 days ago
| Entity Name | Community Health Net |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245209170 PECOS PAC ID: 1759290588 Enrollment ID: O20031222000617 |
News Archive
Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France, the appearance of new CVBDs in Germany, the state of heartworm infection in Korea and the neurological impact on humans of long-term bartonella infection from the USA are among the papers now available for download from http://www.cvbd.org, as the proceedings of the 5th Annual Canine Vector Borne Disease (CVBD) World Forum are made available online today.
The Wistar Institute today obtained a U.S. patent for a novel synthetic vaccine technology with the potential for further development into a universal flu vaccine which could eliminate the need for annual flu shots and protect against future flu pandemics.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Raymond Ignocheck, MD Po Box 369, Erie, PA 16512-0369 Ph: (814) 454-4530 | Anthony Raymond Ignocheck, MD 1202 State St, Erie, PA 16501-1914 Ph: (814) 454-4530 |
News Archive
Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France, the appearance of new CVBDs in Germany, the state of heartworm infection in Korea and the neurological impact on humans of long-term bartonella infection from the USA are among the papers now available for download from http://www.cvbd.org, as the proceedings of the 5th Annual Canine Vector Borne Disease (CVBD) World Forum are made available online today.
The Wistar Institute today obtained a U.S. patent for a novel synthetic vaccine technology with the potential for further development into a universal flu vaccine which could eliminate the need for annual flu shots and protect against future flu pandemics.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
› Verified 6 days ago
Mrs. Marsha Sigrid Dietrich-mclean, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 State St, Erie, PA 16550 Phone: 814-877-4922 Fax: 814-877-3622 | |
Matthew Heitzenrater, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 401, Erie, PA 16507 Phone: 814-877-5333 Fax: 814-877-5329 | |
Dr. Mary Katherine Lasher, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 W 12th St Ste C4, Erie, PA 16505 Phone: 814-461-6626 | |
Matthew Alan Potts, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
David Kruszewski, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3125 French St, Erie, PA 16504 Phone: 814-456-2047 | |
Harry Louis Haus, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3823 W 12th St, Erie, PA 16505 Phone: 814-490-3728 | |
Cecilia T. Urquico, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 W 12th St, Suite 1, Erie, PA 16505 Phone: 814-806-1144 Fax: 814-833-0659 |